The Use of Colistin in Multidrug-Resistant Infections
Antonia ZapantisMary LopezEmily HoffmanAngelica LopezG.M. Hamilton
Abstract
This feature examines the recent rise of colistin use in multidrug-resistant infections and puts it in perspective of its historical use in terms of its safety and tolerability profile. In addition, limitations of using colistin as a first-line agent due to risk of colistin resistance and cases of pandrug resistance are discussed.
Metrics
Citation History
Topics
Related Documents
Colistin shows efficacy in multidrug-resistant infections
Colistin for the treatment of multidrug-resistant infections
Kerry L. LaPlanteJaclyn A. CusumanoGlenn Tillotson
Pharmacokinetics of colistin in patients with multidrug-resistant Gram-negative infections
Vikas GautamNusrat ShafiqJohanW MoutonSameer MalhotraSatinder KaurPallab Ray
Assessment of Colistin Treatment in Multidrug-Resistant Gram-Negative Bacterial Infections
Belgin CoşkunAlpay AzapGülden YılmazMüge AyhanElif Mukime SarıcaoğluMuge AyhanAnkara Sehir Hastanesi, Infeksiyon Hastaliklari ve Klinik Mikrobiyoloji Klinigi, Ankara, TurkiyeElif Mukime SaricaogluAnkara Sehir Hastanesi, Infeksiyon Hastaliklari ve Klinik Mikrobiyoloji Klinigi, Ankara, Turkiye
Safety and efficacy of intravenous colistin (colistin methanesulphonate) for severe multidrug-resistant Gram-negative bacterial infections
Chien‐Yu ChengWang‐Huei ShengJann‐Tay WangYee‐Chun ChenShan‐Chwen Chang